Literature DB >> 10818662

Should sexual partners of women with bacterial vaginosis receive treatment?

J Potter.   

Abstract

Bacterial vaginosis is the most prevalent infectious cause of vaginitis. It is associated with significant morbidity, particularly in pregnant women and following gynaecological operations. Cure is difficult. There is some controversy over whether treating sexual partners of affected women can improve cure rates. This paper provides a critical appraisal of the evidence for simultaneously treating the male partner of women affected by bacterial vaginosis. Unfortunately, no evidence was found supporting the treatment of partners of women affected by bacterial vaginosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10818662      PMCID: PMC1313567     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  18 in total

1.  Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth.

Authors:  J Martius; M A Krohn; S L Hillier; W E Stamm; K K Holmes; D A Eschenbach
Journal:  Obstet Gynecol       Date:  1988-01       Impact factor: 7.661

2.  Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis.

Authors:  M G Gravett; D Hummel; D A Eschenbach; K K Holmes
Journal:  Obstet Gynecol       Date:  1986-02       Impact factor: 7.661

3.  Bacterial vaginosis: a double-blind randomized trial of the effect of treatment of the sexual partner.

Authors:  M Vejtorp; A C Bollerup; L Vejtorp; E Fanøe; E Nathan; A Reiter; M E Andersen; B Strømsholt; S S Schrøder
Journal:  Br J Obstet Gynaecol       Date:  1988-09

4.  Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis.

Authors:  J Swedberg; J F Steiner; F Deiss; S Steiner; D A Driggers
Journal:  JAMA       Date:  1985 Aug 23-30       Impact factor: 56.272

5.  Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome.

Authors:  M G Gravett; H P Nelson; T DeRouen; C Critchlow; D A Eschenbach; K K Holmes
Journal:  JAMA       Date:  1986-10-10       Impact factor: 56.272

6.  Treatment of bacterial vaginosis in women with vaginal bleeding complications or discharge and harboring Mobiluncus.

Authors:  P G Larsson; B Bergman; U Forsum; C Påhlson
Journal:  Gynecol Obstet Invest       Date:  1990       Impact factor: 2.031

7.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

8.  Bacterial vaginosis: microbiological and clinical findings.

Authors:  E Holst; B Wathne; B Hovelius; P A Mårdh
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

9.  Gardnerella vaginalis-associated balanoposthitis.

Authors:  D R Burdge; W R Bowie; A W Chow
Journal:  Sex Transm Dis       Date:  1986 Jul-Sep       Impact factor: 2.830

10.  Should male consorts of women with bacterial vaginosis be treated?

Authors:  H Moi; R Erkkola; F Jerve; G Nelleman; B Bymose; K Alaksen; E Tornqvist
Journal:  Genitourin Med       Date:  1989-08
View more
  11 in total

Review 1.  Antibiotic treatment for the sexual partners of women with bacterial vaginosis.

Authors:  Jairo Amaya-Guio; David Andres Viveros-Carreño; Eloisa Mercedes Sierra-Barrios; Mercy Yolima Martinez-Velasquez; Carlos F Grillo-Ardila
Journal:  Cochrane Database Syst Rev       Date:  2016-10-01

Review 2.  Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation.

Authors:  Catriona S Bradshaw; Jack D Sobel
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

Review 3.  Managing recurrent bacterial vaginosis.

Authors:  J Wilson
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

4.  Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses.

Authors:  Per-Göran Larsson; Erik Brandsborg; Urban Forsum; Sonal Pendharkar; Kasper Krogh Andersen; Salmir Nasic; Lennart Hammarström; Harold Marcotte
Journal:  BMC Infect Dis       Date:  2011-08-19       Impact factor: 3.090

5.  The epidemiology of bacterial vaginosis in relation to sexual behaviour.

Authors:  Hans Verstraelen; Rita Verhelst; Mario Vaneechoutte; Marleen Temmerman
Journal:  BMC Infect Dis       Date:  2010-03-30       Impact factor: 3.090

6.  "It's just an issue and you deal with it… you just deal with it, you move on and you do it together.": Men's experiences of bacterial vaginosis and the acceptability of male partner treatment.

Authors:  Rebecca Wigan; Cathy Vaughn; Lenka Vodstrcil; Michelle Doyle; Marti Kaiser; Collette McGuiness; Catriona S Bradshaw; Jade E Bilardi
Journal:  PLoS One       Date:  2020-06-29       Impact factor: 3.240

7.  Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial.

Authors:  Lenka A Vodstrcil; Ms Erica Plummer; Christopher K Fairley; Gilda Tachedjian; Matthew G Law; Jane S Hocking; Ms Karen Worthington; Ms Mieken Grant; Nita Okoko; Catriona S Bradshaw
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

Review 8.  Making inroads into improving treatment of bacterial vaginosis - striving for long-term cure.

Authors:  Catriona S Bradshaw; Rebecca M Brotman
Journal:  BMC Infect Dis       Date:  2015-07-29       Impact factor: 3.090

9.  Women's Views and Experiences of the Triggers for Onset of Bacterial Vaginosis and Exacerbating Factors Associated with Recurrence.

Authors:  Jade Bilardi; Sandra Walker; Julie Mooney-Somers; Meredith Temple-Smith; Ruth McNair; Clare Bellhouse; Christopher Fairley; Marcus Chen; Catriona Bradshaw
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

10.  Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.

Authors:  Lenka A Vodstrcil; Erica L Plummer; Michelle Doyle; Christopher K Fairley; Colette McGuiness; Deborah Bateson; Jane S Hocking; Matthew G Law; Kathy Petoumenos; Basil Donovan; Eric P F Chow; Catriona S Bradshaw
Journal:  BMC Infect Dis       Date:  2020-11-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.